Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Parren

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Virology|December 1, 1996
In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelopeP W Parren, P Fisicaro, A F Labrijn, et al.
The Journal of General Virology|May 6, 1998
Human recombinant Puumala virus antibodies: cross-reaction with other hantaviruses and use in diagnosticsE M Salonen, P W Parren, Y F Graus, et al.
Immunity|May 6, 1999
Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivoP Poignard, R Sabbe, G R Picchio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997
Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodiesY F Graus, M H de Baets, P W Parren, et al.
Journal of Virology|June 20, 2001
Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12M B Zwick, L L Bonnycastle, A Menendez, et al.
Journal of Virology|June 11, 1999
Ebola virus can be effectively neutralized by antibody produced in natural human infectionT Maruyama, L L Rodriguez, P B Jahrling, et al.
The Journal of Clinical Investigation|October 1, 1992
On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2P W Parren, P A Warmerdam, L C Boeije, et al.
Science (New York, N.Y.)|November 11, 1994
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibodyD R Burton, J Pyati, R Koduri, et al.
Journal of Virology|October 17, 2001
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41M B Zwick, A F Labrijn, M Wang, et al.
Science (New York, N.Y.)|August 11, 2001
Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine designE O Saphire, P W Parren, R Pantophlet, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Virology|December 1, 1996
In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelopeP W Parren, P Fisicaro, A F Labrijn, et al.
The Journal of General Virology|May 6, 1998
Human recombinant Puumala virus antibodies: cross-reaction with other hantaviruses and use in diagnosticsE M Salonen, P W Parren, Y F Graus, et al.
Immunity|May 6, 1999
Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivoP Poignard, R Sabbe, G R Picchio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997
Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodiesY F Graus, M H de Baets, P W Parren, et al.
Journal of Virology|June 20, 2001
Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12M B Zwick, L L Bonnycastle, A Menendez, et al.
Journal of Virology|June 11, 1999
Ebola virus can be effectively neutralized by antibody produced in natural human infectionT Maruyama, L L Rodriguez, P B Jahrling, et al.
The Journal of Clinical Investigation|October 1, 1992
On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2P W Parren, P A Warmerdam, L C Boeije, et al.
Science (New York, N.Y.)|November 11, 1994
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibodyD R Burton, J Pyati, R Koduri, et al.
Journal of Virology|October 17, 2001
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41M B Zwick, A F Labrijn, M Wang, et al.
Science (New York, N.Y.)|August 11, 2001
Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine designE O Saphire, P W Parren, R Pantophlet, et al.
Pageof 6